Novabay Pharmaceuticals Stock Technical Analysis
NBY Stock | USD 0.08 0.0003 0.39% |
As of the 25th of April, NovaBay Pharmaceuticals secures the Standard Deviation of 5.95, risk adjusted performance of (0.09), and Mean Deviation of 4.31. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NovaBay Pharmaceuticals, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have analyzed thirteen technical drivers for NovaBay Pharmaceuticals, which can be compared to its peers in the industry. Please verify NovaBay Pharmaceuticals market risk adjusted performance and treynor ratio to decide if NovaBay Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 0.0773 per share. As NovaBay Pharmaceuticals appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.
NovaBay Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as NovaBay, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NovaBayNovaBay |
NovaBay Pharmaceuticals Analyst Consensus
Target Price | Advice | # of Analysts | |
6.65 | Strong Buy | 2 | Odds |
Most NovaBay analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand NovaBay stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of NovaBay Pharmaceuticals, talking to its executives and customers, or listening to NovaBay conference calls.
NovaBay Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
NovaBay Pharmaceuticals Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of NovaBay Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
NovaBay Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for NovaBay Pharmaceuticals. You can use it to identify possible trend reversals for NovaBay Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual NovaBay Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.NovaBay Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for NovaBay Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.0014 , which may imply that the returns on investment in NovaBay Pharmaceuticals will continue to fail. It has 122 observation points and a regression sum of squares at 0.08, which is the sum of squared deviations for the predicted NovaBay Pharmaceuticals price change compared to its average price change.About NovaBay Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of NovaBay Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of NovaBay Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on NovaBay Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding NovaBay Pharmaceuticals. By analyzing NovaBay Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of NovaBay Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to NovaBay Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 2.66 | 6.13 | 6.05 | 3.5 | Days Of Inventory On Hand | 423.38 | 189.42 | 153.73 | 249.02 |
NovaBay Pharmaceuticals April 25, 2024 Technical Indicators
Most technical analysis of NovaBay help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NovaBay from various momentum indicators to cycle indicators. When you analyze NovaBay charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.09) | |||
Market Risk Adjusted Performance | (1.01) | |||
Mean Deviation | 4.31 | |||
Coefficient Of Variation | (646.00) | |||
Standard Deviation | 5.95 | |||
Variance | 35.38 | |||
Information Ratio | (0.17) | |||
Jensen Alpha | (1.01) | |||
Total Risk Alpha | (1.74) | |||
Treynor Ratio | (1.02) | |||
Maximum Drawdown | 33.93 | |||
Value At Risk | (11.11) | |||
Potential Upside | 7.69 | |||
Skewness | (0.61) | |||
Kurtosis | 1.29 |
NovaBay Pharmaceuticals April 25, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as NovaBay stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 90,054 | ||
Daily Balance Of Power | 0.04 | ||
Rate Of Daily Change | 1.00 | ||
Day Median Price | 0.08 | ||
Day Typical Price | 0.08 | ||
Price Action Indicator | 0.00 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.Note that the NovaBay Pharmaceuticals information on this page should be used as a complementary analysis to other NovaBay Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for NovaBay Stock analysis
When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is NovaBay Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NovaBay Pharmaceuticals. If investors know NovaBay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NovaBay Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.96) | Revenue Per Share 3.494 | Quarterly Revenue Growth 0.023 | Return On Assets (0.25) | Return On Equity (1.39) |
The market value of NovaBay Pharmaceuticals is measured differently than its book value, which is the value of NovaBay that is recorded on the company's balance sheet. Investors also form their own opinion of NovaBay Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NovaBay Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NovaBay Pharmaceuticals' market value can be influenced by many factors that don't directly affect NovaBay Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NovaBay Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NovaBay Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NovaBay Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.